Complicated Intra-abdominal Infection
📧 Sign up to get email alerts when something new happens for Complicated Intra-abdominal Infection.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-09-02FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)
FDA supplemental application for Avycaz (ceftazidime/avibactam) submitted by Allergan to modify the product labeling.
-
FDA label_change · 2007-01-24FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for TYGACIL (tigecycline) submitted by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., to up…